Back to Search
Start Over
Modular Metal-Backed Tibial Components Provide Minimal Mid-Term Survivorship Benefits Despite Increased Cost and Frequency of Use: A Retrospective Review of the American Joint Replacement Registry Database.
- Source :
- Journal of Arthroplasty; Aug2022, Vol. 37 Issue 8, p1570-1570, 1p
- Publication Year :
- 2022
-
Abstract
- <bold>Background: </bold>Previous studies have demonstrated equivalent survivorship of modular metal-backed tibial (MBT) and all-polyethylene tibial (APT) components. The purpose of this study is to compare the utilization and outcomes of APT and MBT components in a large US database.<bold>Methods: </bold>The American Joint Replacement Registry was queried to identify all patients undergoing primary total knee arthroplasty (TKA) during the study period from 2012 to 2019. These patients were divided into cohorts based on tibial component (APT or MBT). Cohort demographics including gender, hospital size, hospital teaching status, region, age, and Charlson Comorbidity Index were reported with descriptive statistics. Overall reoperation rates and revisions for infection, aseptic loosening, periprosthetic fracture, manipulation under anesthesia, and revision for other reasons were identified using International Classification of Diseases, Ninth Revision and Current Procedural Terminology codes and compared across APT and MBT cohorts. Kaplan-Meir survival analysis was performed based on reason for reoperation for APT and MBT.<bold>Results: </bold>During the study period, 703,007 TKAs were reported with 97.8% utilizing MBT and 2.2% utilizing APT components. Despite the introduction of alternative payment models during the study period, the utilization of APT decreased from 5.8% in 2012 to 1.7% in 2019. The survival of APT and MBT TKAs were similar across the study period: 98.1% vs 98.6% at 8 years. The rate of reoperation for all-causes was higher for APT compared to MBT (1.36% vs 1.00%; odds ratio 1.52).<bold>Conclusion: </bold>Despite their paucity of use and lower cost APT remained within a 0.4% margin of survivorship when compared to MBT implants for up to 8 years.<bold>Level Of Evidence: </bold>Level III, retrospective. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 08835403
- Volume :
- 37
- Issue :
- 8
- Database :
- Supplemental Index
- Journal :
- Journal of Arthroplasty
- Publication Type :
- Academic Journal
- Accession number :
- 158261574
- Full Text :
- https://doi.org/10.1016/j.arth.2022.01.031